Compound Evidence File
#EC-2026-0790
DHT (Stanolone)
Filed under Injectable Oils. The bureau holds 102 laboratory returns for this compound from 27 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
27 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 7 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 10.0 | 9.9 | 10.0 | 5 Jan 2026 | 12 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 10.0 | 9.9 | 10.0 | 20 Jan 2026 | 23 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 10.0 | 9.9 | 10.0 | 25 Jan 2026 | 8 Jun 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 10.0 | 10.0 | 13 Mar 2026 | 11 May 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 10.0 | 9.9 | 10.0 | 28 Apr 2026 | 3 Jul 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 9.9 | 9.9 | 10.0 | 11 May 2026 | 10 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 9.9 | 9.9 | 10.0 | 27 Dec 2025 | 11 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 9.9 | 9.9 | 10.0 | 18 Feb 2026 | 6 May 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 9.9 | 9.9 | 9.9 | 1 Apr 2026 | 8 Jun 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 9.9 | 9.9 | 9.9 | 2 Jun 2026 | 2 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 9.9 | 9.9 | 10.0 | 19 Apr 2026 | 24 May 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 9.9 | 9.9 | 10.0 | 22 Mar 2026 | 20 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 9.9 | 9.9 | 9.9 | 22 Mar 2026 | 8 May 2026 |
| Peptronix Bio PTBCASE #VI-2026-0979 | X | 1 | 9.6 | 9.6 | 9.6 | 14 Jan 2025 | 14 Jan 2025 |
| HkRoidsCASE #VI-2026-0784 | X | 1 | 9.5 | 9.5 | 9.5 | 3 Jun 2025 | 3 Jun 2025 |
| BfflinkCASE #VI-2026-0212 | X | 1 | 9.4 | 9.4 | 9.4 | 27 Feb 2025 | 27 Feb 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 2 | 8.7 | 7.3 | 10.0 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 8 | 8.6 | 6.1 | 9.8 | 25 May 2026 | 25 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 8 | 8.5 | 6.9 | 10.0 | 21 May 2026 | 21 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 8 | 8.4 | 6.5 | 9.7 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 8 | 8.2 | 7.3 | 9.4 | 21 May 2026 | 21 May 2026 |
| Bfflist AMOCASE #VI-2026-0678 | X | 6 | 8.2 | 5.0 | 10.0 | 2 Jul 2025 | 17 May 2026 |
| Shandong Aishi BiotechnologyCASE #VI-2026-0308 | X | 3 | 6.2 | 3.5 | 8.0 | 24 Apr 2025 | 24 May 2026 |
| Heman Peptide HMCASE #VI-2026-0089 | X | 2 | 6.0 | 4.8 | 7.3 | 6 May 2025 | 17 May 2026 |
| Xianhong Tong XHT PeptidesCASE #VI-2026-0997 | X | 1 | 4.9 | 4.9 | 4.9 | 24 Apr 2025 | 24 Apr 2025 |
Open any subject to view the batch-level evidence for DHT (Stanolone) alone.